FY25 EPS consensus $1.26. Lowers FY25 revenue view to $1.85B-$1.87B from $2.1B-$2.12B, consensus $2.12B. Lowers adjusted EBITDA view to $445M-$455M from $525M-$535M. With the reclassification of the ...
CVS Health Corporation CVS posted second-quarter 2025 adjusted earnings per share (EPS) of $1.81, down 1.1% year over year. The metric topped the Zacks Consensus Estimate by 23.1%. The adjusted EPS ...
Medtronic plc MDT reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $1.26, which rose 2.4% from the year-ago quarter’s figure and beat the Zacks Consensus Estimate by 2.4%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results